Bonus BioGroup (XTAE:BONS) Total Liabilities : ₪16.45 Mil (As of Dec. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Bonus BioGroup Total Liabilities?

Bonus BioGroup's Total Liabilities for the quarter that ended in Dec. 2024 was ₪16.45 Mil.

Bonus BioGroup's quarterly Total Liabilities increased from Jun. 2024 (₪16.62 Mil) to Sep. 2024 (₪17.63 Mil) but then declined from Sep. 2024 (₪17.63 Mil) to Dec. 2024 (₪16.45 Mil).

Bonus BioGroup's annual Total Liabilities declined from Dec. 2022 (₪18.22 Mil) to Dec. 2023 (₪15.58 Mil) but then increased from Dec. 2023 (₪15.58 Mil) to Dec. 2024 (₪16.45 Mil).

Bonus BioGroup Total Liabilities Historical Data

The historical data trend for Bonus BioGroup's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bonus BioGroup Total Liabilities Chart

Bonus BioGroup Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

20.75

19.89

18.22

15.58

16.45

Bonus BioGroup Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															15.58	16.88	16.62	17.63	16.45

Bonus BioGroup Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Bonus BioGroup's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7.916	+	(8.533	+	1.7763568394003E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	16.45

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	23.406	-	6.957
	=	16.45

Bonus BioGroup's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7.916	+	(8.533	+	1.7763568394003E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	16.45

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	23.406	-	6.957
	=	16.45

Bonus BioGroup Total Liabilities Related Terms

Thank you for viewing the detailed overview of Bonus BioGroup's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Bonus BioGroup Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bonus BioGroup Ltd (XTAE:BONS) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

BBIXF:USA

Address

Matam Advanced, Technology Park, P.O.B 15143, Haifa, ISR, 31905

Website

https://www.bonus-bio.com

Bonus BioGroup Ltd is an clinical-stage biotechnology company developing next-generation therapies for a variety of indications in the regenerative medicine field. Its products products, BonoFill and MesenCure.

Bonus BioGroup Headlines

No Headlines